Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2. Zhu Y, Li M, Liu N, Wu T, et al. Antiviral Res 2023;211:105541.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu Y, Li M, Liu N, Wu T, et al. Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2. Antiviral Res 2023;211:105541.
PMID: 36682464